Table of Contents

company-logo

Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP5063, which is in Phase III clinical trials for the treatment of schizophrenia, as well as completed Phase I clinical trials to treat bipolar disorder, major depressive disorder, attention–deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity disorder, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis. It is also developing RP1208 that is in pre-clinical development studies for the treatment of depression and obesity. The company is headquartered in Cupertino, California.

Reviva Pharmaceuticals Dividend Announcement

• Reviva Pharmaceuticals does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Reviva Pharmaceuticals dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Reviva Pharmaceuticals Dividend History

Reviva Pharmaceuticals Dividend Yield

Reviva Pharmaceuticals current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Reviva Pharmaceuticals stock? Use our calculator to estimate your expected dividend yield:

Reviva Pharmaceuticals Financial Ratios

P/E ratio-1.21
PEG ratio0.00
P/B ratio-3.24
ROE664.92%
Payout ratio0.00%
Current ratio0.41
Quick ratio0.41
Cash Ratio0.38

Reviva Pharmaceuticals Dividend FAQ

Does Reviva Pharmaceuticals stock pay dividends?
Reviva Pharmaceuticals does not currently pay dividends to its shareholders.
Has Reviva Pharmaceuticals ever paid a dividend?
No, Reviva Pharmaceuticals has no a history of paying dividends to its shareholders. Reviva Pharmaceuticals is not known for its dividend payments.
Why doesn't Reviva Pharmaceuticals pay dividends?
There are several potential reasons why Reviva Pharmaceuticals would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Reviva Pharmaceuticals ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Reviva Pharmaceuticals has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Reviva Pharmaceuticals a dividend aristocrat?
Reviva Pharmaceuticals is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Reviva Pharmaceuticals a dividend king?
Reviva Pharmaceuticals is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Reviva Pharmaceuticals a dividend stock?
No, Reviva Pharmaceuticals is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Reviva Pharmaceuticals stocks?
To buy Reviva Pharmaceuticals you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Reviva Pharmaceuticals stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.